High-qualty aluminum-doped zinc oxide layer as transparent conductive electrode for organic light-emitting devices
    61.
    发明授权
    High-qualty aluminum-doped zinc oxide layer as transparent conductive electrode for organic light-emitting devices 有权
    高质量的铝掺杂氧化锌层作为有机发光器件的透明导电电极

    公开(公告)号:US06917158B2

    公开(公告)日:2005-07-12

    申请号:US10093940

    申请日:2002-03-08

    IPC分类号: H01L51/52 H05B33/00

    CPC分类号: H01L51/5206

    摘要: An organic light-emitting diode is described in which the anode comprises midfrequency magnetron sputtered aluminum-doped zinc oxide to increase the device stability and to decrease the material cost. Due the novel deposition technique, ZnO:Al film with ITO-like electrical conductivity can be deposited and improved device performance, especially the long-term stability can be obtained which are attributed to the modification of the ZnO:Al conductivity and surface chemistry.

    摘要翻译: 描述了一种有机发光二极管,其中阳极包括中频磁控溅射铝掺杂氧化锌以增加器件稳定性并降低材料成本。 由于新颖的沉积技术,可以沉积具有ITO样导电性的ZnO:Al膜,并提高器件性能,特别是由于ZnO:Al导电性和表面化学性质的改变,可以获得长期稳定性。

    Electronic book content protection
    63.
    发明授权
    Electronic book content protection 有权
    电子书内容保护

    公开(公告)号:US09015851B2

    公开(公告)日:2015-04-21

    申请号:US13453146

    申请日:2012-04-23

    IPC分类号: G06F21/10 G06F21/62

    摘要: A system and method are disclosed for protecting an electronic book from unauthorized access. HTML for the book is shredded by dividing it into portions, and a selection scheme is used to intersperse decoy data among the portions. Dynamically generated cascading style sheets are used to define a pattern for decoy and content data such that a browser on a client device correctly processes the HTML but an unauthorized program such as a web scraper cannot correctly process the HTML.

    摘要翻译: 公开了一种用于保护电子书防止未授权访问的系统和方法。 通过将书划分成多个部分,将书籍的HTML打碎,并使用选择方案来在这些部分之间插入诱饵数据。 使用动态生成的级联样式表来定义诱饵和内容数据的模式,使得客户端设备上的浏览器正确处理HTML,但是诸如Web刮板之类的未经授权的程序无法正确处理HTML。

    BABY MONITORING MAT BASED ON FIBER OPTIC SENSOR
    64.
    发明申请
    BABY MONITORING MAT BASED ON FIBER OPTIC SENSOR 有权
    基于光纤传感器的婴儿监视器

    公开(公告)号:US20130109931A1

    公开(公告)日:2013-05-02

    申请号:US13700660

    申请日:2011-03-03

    IPC分类号: A61B5/08 A61B5/00 A61B5/11

    摘要: The present invention provides a baby monitoring mat having a sensor mat having a top mesh layer, a bottom mesh layer, and two flexible sheets and an optical cable, wherein the optical cable is routed across and sandwiched in between the top mesh layer and the bottom mesh layer, and the flexible sheets further sandwiched the top mesh layer and the bottom mesh layer in between forming sensing area across the flexible sheet surface; a light source for feeding light from one side of the optical cable; a photodiode for detecting light attenuation at the other end of the optical cable; a printed circuit board having a processor connected to the light source and the photodiode, wherein the processor operationally receives signals from the photodiode, the signals are processed to determine movements and breath counts. The signals are generated based on the light attenuation changes along the optical fiber cable detected by photodiode, the light attenuation changes are operationally caused by the optical fiber bending lost caused by the movements and breath. A method for monitoring baby on a mat is also provided.

    摘要翻译: 本发明提供了一种具有传感器垫的婴儿监护垫,该传感器垫具有顶部网层,底部网状层,以及两个柔性片和光缆,其中光缆穿过并夹在顶部网状物层和底部 网状层,并且柔性片材进一步夹在顶部网状物层和底部网状物层之间,形成感应区域穿过柔性片材表面; 用于从光缆的一侧馈送光的光源; 用于检测光缆另一端的光衰减的光电二极管; 具有连接到光源和光电二极管的处理器的印刷电路板,其中处理器可操作地接收来自光电二极管的信号,处理信号以确定运动和呼吸计数。 基于由光电二极管检测到的光纤电缆的光衰减变化产生信号,光衰减变化在操作上是由于运动和呼吸引起的光纤弯曲损耗引起的。 还提供了一种用于在垫上监测婴儿的方法。

    GENERATION OF VASCULARIZED HUMAN HEART TISSUE AND USES THEREOF
    65.
    发明申请
    GENERATION OF VASCULARIZED HUMAN HEART TISSUE AND USES THEREOF 有权
    血管化人心脏组织的产生及其用途

    公开(公告)号:US20120135051A1

    公开(公告)日:2012-05-31

    申请号:US13375402

    申请日:2010-06-10

    摘要: The present invention relates to the generation of vascularized human heart tissue from human primordial Islet1-positive (ISL1+) progenitors, and more particularly the generation of vascularized human heart tissue from human primordial Islet1+ cardiovascular stem cells which are positive for markers ISL1+/NKX2.5−/KDR−. One aspect of the invention relates to isolation of human ISL1+ primordial cells from human pluripotent cells, such as human ES cells or other human pluripotent stem cell sources, wherein the human ISL1+ primordial cells can differentiate into three different lineages; cardiomyocyte lineages, endothelial lineages and smooth muscle lineages. Another aspect relates to use and implantation of the human primordial ISL1+ progenitors into an animal model to generate human vascularized heart tissue, and more particularly, the production of an in vivo humanized model of vascular disease. One embodiment relates to the use of an in vivo humanized model of vascular disease as an assay, for example to assess drug toxicity and/or identify agents which increase and decrease coronary blood flow to the human vascularized heart tissue. Another embodiment relates to the therapeutic use of human primordial ISL1+ progenitors, for example, in one embodiment the invention provides methods for the treatment cardiovascular disorders and/or congenital heart disease in a subject comprising transplanting into subjects vascularized human heart tissue generated from human ISL1+ progenitors.

    摘要翻译: 本发明涉及从人原始Islet1阳性(ISL1 +)祖细胞产生血管化人心脏组织,更具体地说,从人原代Islet1 +心血管干细胞产生血管化人心脏组织,其对于标志物ISL1 + / NKX2.5是阳性的 - / KDR-。 本发明的一个方面涉及从人多能细胞例如人ES细胞或其他人多能干细胞来源分离人ISL1 +原始细胞,其中人ISL1 +原始细胞可分化成三种不同谱系; 心肌细胞谱系,内皮谱系和平滑肌谱系。 另一方面涉及将人原始ISL1 +祖细胞用于和植入动物模型中以产生人血管化的心脏组织,更具体地,涉及血管疾病的体内人源化模型的产生。 一个实施方案涉及血管疾病的体内人源化模型的用途作为测定,例如用于评估药物毒性和/或鉴定增加和减少冠心病血液流向人血管化心脏组织的药剂。 另一个实施方案涉及人原始ISL1 +祖细胞的治疗用途,例如,在一个实施方案中,本发明提供了治疗受试者心血管疾病和/或先天性心脏病的方法,所述方法包括移植入受试者从人ISL1 +祖细胞产生的血管化人心脏组织 。

    Robust self-aligned process for sub-65nm current-perpendicular junction pillars
    69.
    发明授权
    Robust self-aligned process for sub-65nm current-perpendicular junction pillars 有权
    用于sub-65nm电流垂直连接柱的鲁棒自对准工艺

    公开(公告)号:US07993535B2

    公开(公告)日:2011-08-09

    申请号:US11627824

    申请日:2007-01-26

    CPC分类号: H01L43/12

    摘要: A method for fabricating a device includes forming a first insulation layer to cover a removable mask and a device structure that has been defined by the mask. The device structure is below the mask. The mask is lifted off to expose a top portion of the device structure. A conductive island structure is formed over the first insulation layer and the exposed top portion of the device structure. The first insulation layer and the conductive island structure are covered with a second insulation layer. A contact is formed through the second insulation layer to the conductive island structure.

    摘要翻译: 一种用于制造器件的方法包括形成第一绝缘层以覆盖可去除的掩模和由掩模限定的器件结构。 器件结构在掩模之下。 提起面罩以露出装置结构的顶部。 在第一绝缘层和器件结构的暴露顶部上形成导电岛结构。 第一绝缘层和导电岛结构被第二绝缘层覆盖。 通过第二绝缘层向导电岛结构形成接触。

    Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods
    70.
    发明授权
    Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods 有权
    神经活性13,24-环-18,21-二硼胆碱和结构相关的五环类固醇

    公开(公告)号:US07781421B2

    公开(公告)日:2010-08-24

    申请号:US10856314

    申请日:2004-05-28

    摘要: Novel pentacyclic steroids and pentacyclic D-homosteroids comprising: (i) the tetracyclic steroid ring system or tetracyclic D-homosteroid ring system, respectively; (ii) a C(3) substituent selected from the group consisting of (a) a hydroxyl or carboxyl in the α-configuration and (b) a sulfate or other negatively charged moiety; and (iii) a fused fifth ring, the fused fifth ring comprising a hydrogen bond acceptor, and (a) in the case of the pentacyclic steroid the C(13) and C(17) carbons, or (b) in the case of the pentacyclic D-homosteroid the C(13) and C(17a) carbons, having utility as anesthetics and in the treatment of disorders relating to GABA function and activity.

    摘要翻译: 新型五环类固醇和五环D-类固醇激素分别包括:(i)四环类固醇环系统或四环D-类固醇环系统; (ii)选自(a)α-构型的羟基或羧基和(b)硫酸盐或其它带负电荷的部分的C(3)取代基; 和(iii)稠合的第五环,所述稠合的第五环包含氢键受体,和(a)在五环类固醇的情况下,C(13)和C(17)的碳,或(b)在 五环D-类固醇,C(13)和C(17a)碳,可作为麻醉剂用于治疗与GABA功能和活性有关的疾病。